Inavolisib, CAS [[2060571-02-8]]

Produktübersicht

• Artikelname: Inavolisib, CAS [[2060571-02-8]]
• Artikelnummer: MCE-HY-101562
• Hersteller Artikelnummer: HY-101562
• Alternativnummer: MCE-HY-101562-50MG,MCE-HY-101562-25MG,MCE-HY-101562-100MG,MCE-HY-101562-1MG,MCE-HY-101562-10MG,MCE-HY-101562-5MG,MCE-HY-101562-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: GDC-0077, RG6114

Produktbeschreibung

Inavolisib (GDC-0077) is a potent, orally active, and selective PI3Kalpha inhibitor (IC50=0.038 nM). Inavolisib exerts its activity by binding to the ATP binding site of PI3K, thereby inhibiting the phosphorylation of PIP2 to PIP3. Inavolisib is more selective for mutant versus wild-type PI3Kalpha. Inavolisib can be used for the study of breast cancer[1].

Produkteigenschaften

• Molekulargewicht: 407.37
• Reinheit: 99.96
• CAS Nummer: [2060571-02-8]
• Formel: C18H19F2N5O4
• Target-Kategorie: Apoptosis,PI3K

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound